Hyamax® Extra Deep (2 x 2.0 mL) | Laboratories Hyamed SA
Short Description
A high-viscoelasticity, structural Hyaluronic Acid dermal filler formulated with 20 mg/mL of BDDE cross-linked HA. Supplied in an economical 2.0 mL high-capacity syringe, Hyamax® Extra Deep is engineered for mid-to-deep dermal and subcutaneous placement to treat severe facial folds, sculpt cheek and chin architecture, contour the jawline, and reconstruct lost anatomical volume with natural tissue integration lasting 12 to 18 months.
Detailed Description
Hyamax® Extra Deep is an advanced, sterile, non-pyrogenic physiological cross-linked sodium hyaluronate injectable developed by Laboratories Hyamed SA (Geneva, Switzerland). Formulated specifically for deep soft-tissue augmentation and structural facial remodeling, it provides high mechanical projection combined with smooth biological tissue integration.
Produced via non-animal bacterial bio-fermentation, Hyamax Extra Deep utilizes an advanced multi-stage cross-linking process that bonds hyaluronic acid chains into a cohesive three-dimensional polymer network. This molecular architecture delivers a high elastic modulus ($G’$) and viscosity, allowing the hydrogel to withstand compressive forces and dynamic muscle shear (such as the masseter, mentalis, and zygomaticus complexes) without flattening, migrating, or losing definition.
Subjected to exhaustive post-synthesis dialysis, residual unreacted BDDE monomers and bacterial endotoxins are reduced to non-detectable trace levels, significantly minimizing post-procedure tissue edema, erythema, and immune hypersensitivity. With its high-capacity 2.0 mL format, Hyamax Extra Deep provides practitioners with double the product volume of conventional 1.0 mL syringes, allowing complete multi-zone facial restoration in a single clinical unit.
Treatment Areas & Indications
-
Severe Facial Folds & Depressions:
-
Severe nasolabial folds (deep creases extending from the nasal ala to the oral commissures)
-
Deep marionette lines and oral commissure structural descent
-
Deep labiomental furrow (mental crease between lower lip and chin)
-
-
Midface Structural Volumization:
-
Malar and cheekbone augmentation (Zygomatic arch projection)
-
Submalar hollow correction and deep medial fat compartment restoration
-
Temporal hollow restoration (temple lifting)
-
-
Lower Face Contouring & Harmonization:
-
Chin augmentation, forward projection, and vertical lengthening (retrognathia / microgenia correction)
-
Mandibular angle definition and crisp linear jawline sculpting
-
Pre-jowl sulcus structural effacement
-
-
Facial Remodeling & Tissue Repair:
-
Non-surgical rhinoplasty (dorsal bridge straightening and nasal tip support)
-
Deep atrophic scar tissue elevation and structural repair
-
Key Clinical Advantages
-
High-Capacity 2.0 mL Syringe: Delivers twice the volume of standard 1.0 mL industry syringes, making it highly cost-efficient and practical for bilateral cheek sculpting or comprehensive lower-face contouring.
-
Superior Elastic Modulus ($G’$) & Projection: Generates high resistance to tissue compression, creating defined bone-mimetic projection that holds its vertical height without lateral spreading.
-
Exhaustive Dialysis Purification: Rigorous washing cycles eliminate residual cross-linkers and bacterial proteins, minimizing post-injection edema, erythema, and downtime.
-
Anti-Migration Cohesivity: The dense polymer matrix anchors deep boluses securely at the target anatomical plane, preventing displacement into adjacent superficial tissue layers.
-
Smooth Injection Mechanics: Despite its high viscosity, the cohesive hydrogel extrudes evenly through 27G needles, granting the practitioner pinpoint volumetric control during deep bolus or retrograde deposition.
-
Extended Clinical Longevity: Highly resistant to mechanical breakdown and enzymatic degradation by endogenous hyaluronidase, sustaining structural volume for 12 to 18 months.
Technical Specifications
| Parameter | Specification |
| Active Substance | Cross-linked Sodium Hyaluronate (non-animal bio-fermentation) |
| HA Concentration | 20 mg/mL (High-density structural matrix) |
| Cross-Linking Technology | Multi-Stage Cohesive BDDE 3D Hydrogel Matrix |
| Lidocaine Content | Available without lidocaine or with 0.3% Lidocaine HCl (Extra Deep L-Plus) |
| Syringe Volume | 2 x 2.0 mL pre-filled sterile glass syringe (Total 2.0 mL) |
| Included Needles | 2 x 27G 1/2” (13 mm) ultra-thin wall disposable needles |
| Target Injection Plane | Mid-to-deep dermis, deep subcutaneous tissue, or supraperiosteal plane |
| Recommended Injection Tools | 27G needle or 22G / 25G blunt-tip microcannula |
| Expected Clinical Duration | 12 to 18 months (dependent on anatomical site, depth, and patient tissue metabolism) |
| Storage Instructions | Store between 2°C to 25°C (36°F to 77°F); protect from direct sunlight and freezing |
| Manufacturer / Origin | Laboratories Hyamed SA (Geneva, Switzerland) |
| Regulatory Category | CE-marked Class III Medical Device / Prescription Only (Rx) |
Professional Advisory: Hyamax® Extra Deep is a high-density medical injectable intended strictly for certified dermatologists, plastic surgeons, and credentialed aesthetic physicians trained in deep facial anatomy, supraperiosteal bolus delivery, and vascular safety. Not authorized for superficial intradermal injection or non-clinical consumer use.






Reviews
There are no reviews yet.